There are 2789 resources available
1805P - Assistance with an artificial intelligence-powered PD-L1 analyzer reduces interobserver variation in pathologic reading of tumor proportion score in non-small cell lung cancer
Presenter: Sangjoon Choi
Session: ePoster Display
1806P - Analysis of germ-line mutations in non-syndromic malignancies with concurrent pathogenic variants in BRCA1, BRCA2, PALB2, ATM, CHEK2, and RAD51C/D
Presenter: Emily Miller
Session: ePoster Display
Resources:
Abstract
1807P - Pan-cancer analysis of SMARCA4 genomic alterations to reveal a complex molecular landscape
Presenter: Qinpeng Xie
Session: ePoster Display
1808P - MET fusions as therapeutic targets in solid tumors
Presenter: Sabrina Borchert
Session: ePoster Display
1809P - Evaluation of KRAS mutation subtype on survival in patients with metastatic non-small cell lung cancer receiving immunotherapy
Presenter: Carly Barron
Session: ePoster Display
1810P - Tumor metabolite lactate promotes tumorigenesis through modulating Moesin lactylation and TGF-b signaling of regulatory T cells
Presenter: Jian Gu
Session: ePoster Display
Resources:
Abstract
1811P - Molecular characterization of epidermal growth factor receptor-mutated (EGFR-m) non-small cell lung cancer (NSCLC) undergoing histological transformation
Presenter: Laura Bonanno
Session: ePoster Display
1812P - Clinical and pathological features and prognosis of non-small cell lung cancer (NSCLC) patients with adenocarcinomas without TTF1 and Napsin A expression
Presenter: Franziska Kraus
Session: ePoster Display
1813P - Anlotinib plus osimertinib overcomes acquired resistance to osimertinib via FGFR and EGFR signaling in non-small cell lung cancer (NSCLC)
Presenter: Qiong Zhao
Session: ePoster Display
1814P - Molecular profile and clinical data of patients with lung cancer harboring germline TP53 R337H mutation
Presenter: Carlos Diego Lopes
Session: ePoster Display